Primary Recipient

BETH ISRAEL DEACONESS MEDICAL CENTER INC

Amount

$996,214.00

Award Date

9/29/2009

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

This application addresses broad Challenge Area (05) Comparative Effectiveness Research and specific Topic 05-CA-104* Comparative Effectiveness Research on Cancer Treatment. Effectiveness of prostate cancer treatment has been previously evaluated by Marko

Recipients Connected to Award

Recipient	Role	Amount
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO	Sub-recipient	$477,304.00
BETH ISRAEL DEACONESS MEDICAL CENTER INC	Primary recipient	$259,722.32
MICHIGAN STATE UNIVERSITY	Sub-recipient	$78,461.00
DANA-FARBER CANCER INSTITUTE, INC.	Sub-recipient	$59,790.00
UNIVERSITY OF CALIFORNIA, LOS ANGELES	Sub-recipient	$24,366.00
BRIGHAM AND WOMEN'S HOSPITAL, INC., THE	Sub-recipient	$24,305.00
CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE/CWRU	Sub-recipient	$24,288.00
WASHINGTON UNIVERSITY, THE	Sub-recipient	$24,039.68
REGENTS OF THE UNIVERSITY OF MICHIGAN	Sub-recipient	$23,938.00